Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds GT Biopharma Q3 EPS $(0.22) Down From $(0.17) YoY

GT Biopharma Q3 EPS $(0.22) Down From $(0.17) YoY

GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(0.22) per share. This is a 29.41 percent decrease over losses of $(0.17) per share from the same period last year.

byMichael Horton

October 31, 2022

1 minute read

GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(0.22) per share. This is a 29.41 percent decrease over losses of $(0.17) per share from the same period last year.

Top 3 Risk Off Stocks Could Blast Off This Quarter

By Lisa Levin

May 8, 7:48 AM

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

ASAI

What’s Going On With Nikola Corporation Stock?

By Erica Kollmann

September 8, 10:38 AM

Nikola Corporation (NASDAQ: NKLA) shares are trading lower on Friday. The stock is down more than 60% over the last month. What To Know:

NKLA

Precision Drilling Q2 EPS $(1.42) Beats $(1.85) Estimate, Sales $255.47M Beat $226.61M Estimate

By Bill Haddad

July 27, 6:13 AM

Precision Drilling (NYSE:PDS) reported quarterly losses of $(1.42) per share which beat the analyst consensus estimate of $(1.85) by 23.24 percent. This is a 69.46 percent increase over losses of $(4.65) per share from

PDS